Navigation Links
Dyadic International Reports Third Quarter 2013 Financial Results
Date:11/14/2013

SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Nine Months Ended September 30, 20132012 (Unaudited)  (Unaudited) Operating Activities Net Income 

$

120,647$

2,797,037 Adjustments to Reconcile Net Income to Net Cash (Used in) Operating Activities:  Depreciation and Amortization of Fixed Assets 145,404156,148 Amortization of Intangible and Other Assets 38,18138,182 Increase (Decrease) in Allowance for Doubtful Accounts (315,567)65,345 Increase in Inventory Reserve 80,000161,000 Compensation Expense on Stock Option Grants 562,375956,102 Changes in Operating Assets and Liabilities:  Accounts Receivable (312,015)29,478 License Fee Receivable 2,708,750(5,500,000) Inventory 1,006,326186,120 Prepaid Expenses and Other Current Assets 53,924(18,585) Accounts Payable 92,769(396,457) Accrued Expenses 373,129(47,204) Accrued Interest Payable 169,8561,774 Income Taxes Payable 38,00065,000 Deferred Research and Development Obligation (252,612)714,181 Net Cash Provided By (Used In) Operating Activities 4,509,167(791,879) Investing Activities  Purchases of Fixed Assets (147,986)(9,266) Cost of Patents (68,013)(58,291) Restricted Cash(4,441)(1,377) Net Cash (Used In) Investing Activities (220,440)(68,934) Financing Activities  Proceeds from Warrant Exercises 159,044- Proceeds from Stock Option Exercises 58,50037,075 Net Cash Provided by Financing Activities 217,54437,075 Net Increase (Decrease) in Cash and Cash Equivalents 4,506,271(823,738) Cash and Cash Equivalents at Beginning of Period 3,990,0623,691,755 Cash and Cash Equivalents at End of Period 

$

8,496,333$

2,868,017 Supplemental Cash F
'/>"/>

SOURCE Dyadic International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Dyadic International Partners with Leading Provider of Nutritional Ingredient Solutions for Production of Food Enzymes
2. Dyadic International Launches FibreZyme® G5000 High Performance Powder Pulp and Paper Enzyme in Booth #1065 at Tissue World Americas Conference
3. Dyadic International To Release First Quarter 2012 Financial Results And Host Conference Call
4. Dyadic Demonstrates Industry-leading Biofuels Enzyme Performance
5. Dyadic International to Announce Second Quarter 2012 Financial Results and Host Conference Call on Monday, August 13, 2012
6. Dyadic Netherlands To Develop Baking Enzymes For EU-Funded Research Project
7. Dyadic International Reports 2012 Third Quarter Financial Results
8. 12th U.S. Patent Issued To Dyadic International
9. Dyadic International Upgraded By OTC Markets To "Current Information" Tier
10. Dyadic International To Announce Year-End 2012 Financial Results And Host Conference Call On Thursday, March 7, 2013
11. Dyadic International To Present At World Biofuels Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/27/2014)... , Oct. 27, 2014 Kalorama Information says ... Ebola concern in the United States ... The healthcare market researcher said the FDA,s Emergency Use Authorization ... diagnostic tests for the detection of the Ebola virus ... useful.  Kalorama routinely assess the IVD industry and its ...
(Date:10/27/2014)... Florida (PRWEB) October 27, 2014 ... at reducing and eliminating several types of pediatric ... not been achieved in over 30 years of ... Noah's Light Foundation, proves that one mom's determination ... diagnosed just before Halloween trick-or-treating, and it’s only ...
(Date:10/27/2014)... HORSHAM, Pa. , Oct. 27, 2014 /PRNewswire/ ... Colitis Foundation of America (CCFA) announced today the ... , an educational campaign designed ... bowel diseases (IBD) on the paired role of ... To view the multimedia assets associated with ...
(Date:10/26/2014)... The report "Protective Coatings Market by ... Trends & Forecast to 2019", defines and segments the ... volume consumed and value generated. The protective coatings consumption ... to 6,701.3 KT by 2019, at a CAGR of ... data tables and 22 figures spread through 219 slides ...
Breaking Biology Technology:Kalorama: PCR The Go-to Test in Ebola Fight 2Kalorama: PCR The Go-to Test in Ebola Fight 3FDA Approves Breakthrough in Pediatric Brain Cancer - First in 30 Years 2FDA Approves Breakthrough in Pediatric Brain Cancer - First in 30 Years 3Celebrity Cook Sunny Anderson Teams Up With Janssen And Crohn's & Colitis Foundation Of America To Launch Educational Campaign 2Celebrity Cook Sunny Anderson Teams Up With Janssen And Crohn's & Colitis Foundation Of America To Launch Educational Campaign 3Celebrity Cook Sunny Anderson Teams Up With Janssen And Crohn's & Colitis Foundation Of America To Launch Educational Campaign 4Protective Coatings Market Poised to Reach $18,431.8 Million by 2019 - Report by MarketsandMarkets 2Protective Coatings Market Poised to Reach $18,431.8 Million by 2019 - Report by MarketsandMarkets 3Protective Coatings Market Poised to Reach $18,431.8 Million by 2019 - Report by MarketsandMarkets 4
... COLUMBIA, Md., May 22 Martek Biosciences,Corporation (Nasdaq: ... results,of its second quarter of fiscal 2008 on June ... the release, at 4:45 p.m. ET Martek will,conduct a ... quarter of,fiscal 2008 with investors. All interested parties may ...
... for profit, WASHINGTON, May 22 Medtronic ... to pay $75,000,000 to the federal government to,settle ... device,company,s sales and pricing strategy to increase its ... lawsuit, which the government joined, was,kept under seal ...
... Nektar,Therapeutics (Nasdaq: NKTR ) announced today ... as Chief Operating Officer and Head of the,PEGylation ... aspects of the PEGylation Business Unit, including research,and ... He will also,serve as Chairman of Nektar India ...
Cached Biology Technology:Medtronic Unit to Pay $75 Million to Settle Whistleblower Medicare Fraud Case 2Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit 2Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit 3
(Date:10/29/2014)... of its kind to date, researchers have used DNA ... risk for autism. Joseph Buxbaum, Ph.D., Icahn School of ... Ph.D., Broad Institute of Harvard and MIT, and their ... children, parents and unrelated people. They identified changes in ... risk for autism spectrum disorder (ASD) – a jump ...
(Date:10/29/2014)... Online registration is open for the ... Scientific Meeting. SIR 2015 is the one ... trainees and related health care professionals can ... image-guided science and technologies being presented, discussed ... community in minimally invasive, image-guided medicine, SIR ...
(Date:10/29/2014)... Plants rely on sunlight to make their food, but they ... do. Recently, scientists discovered a group of molecules in plants ... in the Journal of the American Chemical Society , ... plant sunscreens work. , Timothy Zwier and colleagues at Purdue ... to daily can cause serious damage to plant DNA and, ...
Breaking Biology News(10 mins):SIR 2015: Interventional radiology shapes tomorrow's medicine 2
... with a number of pathological conditions, including cancer. Publishing in ... in drinking water given at the maximum levels permitted ... in mice. On the other hand, reducing copper levels reduced ... essential factor for the growth of tumors in humans as ...
... Hall Institute have been awarded more than $2.2 million from ... disorders and inflammatory diseases. Three institute researchers - ... - were announced last week as recipients of ARC Future ... body controls errant immune cells that cause type 1 diabetes ...
... , Nov. 14, 2013  Based on its recent research ... presents Cognitec Systems GmbH with the 2013 European ... Cognitec,s blinkers-on focus on face biometrics earned the ... to develop its flagship face recognition technology, FaceVACS-VideoScan. ...
Cached Biology News:Copper intake makes tumors breathe 2ARC Future Fellows awarded $2.2M for immune and inflammation studies 2Frost & Sullivan Honours Cognitec for Blazing Trails in the Face Biometrics Market with its FaceVACS-VideoScan Technology 2Frost & Sullivan Honours Cognitec for Blazing Trails in the Face Biometrics Market with its FaceVACS-VideoScan Technology 3Frost & Sullivan Honours Cognitec for Blazing Trails in the Face Biometrics Market with its FaceVACS-VideoScan Technology 4Frost & Sullivan Honours Cognitec for Blazing Trails in the Face Biometrics Market with its FaceVACS-VideoScan Technology 5
Human DPPII/QPP/DPP7 Biotinylated Affinity Purified PAb ENTREZ GeneID: 29952...
Homo sapiens formin-like...
Mouse Ameloblastin Biotinylated Affinity Purified PAb ENTREZ GeneID: 11698...
... GRASP1 ( Abpromise for all ... Synthetic peptide corresponding to amino ... region of rat GRASP1, conjugated to ... Entrez GeneID: 56850 ...
Biology Products: